e-learning
resources
London 2016
Sunday, 04.09.2016
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Robert Lins (Antwerp, Belgium), Robert Lins, Haiko Pillu, Lien Gheyle, Annick Van Riel
Source:
International Congress 2016 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster
Number:
1060
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert Lins (Antwerp, Belgium), Robert Lins, Haiko Pillu, Lien Gheyle, Annick Van Riel. Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting. Eur Respir J 2016; 48: Suppl. 60, 1060
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
Year: 2019
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease
Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Year: 2018
A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
The role of screening in early diagnosis of COPD
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010
Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021
Year: 2022
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018
Year: 2018
Evaluation of new biomarkers for laboratory diagnosis of tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Interference RNA as a new tool and possible future therapy for inflammatory lung disease
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005
Monitoring of early lung disease: Is it clinically important to do routine infant lung function test?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004
The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Characterisation of clinical phenotypes is mandatory for the development of new drugs
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
What is the best biomarker of COVID-19 pneumonia progression?
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Strategy for early diagnosis and intervention in chronic respiratory disease
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Which tools to improve early diagnosis of COPD in primary care?
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept